Dr. Michael Liebowitz, a member of WCG’s Scientific Leadership Team, shared his insights during a recent conversation with Mark Opler, PhD, MPH, chief research officer at WCG’s MedAvante-ProPhase. Dr. Liebowitz, a pioneer in social anxiety disorders, is a Columbia University psychiatrist and founder of the Anxiety Disorders Clinic, the first of its kind, at the New York State Psychiatric Institute. He also developed the Liebowitz Social Anxiety Scale (LSAS).
Request a Genetics in Clinical Trials training session
What You'll LearnMost Recent Flipbooks
Ideal vs. Reality Budgeting - Create & Negotiate the Best Clinical Trial Budget for Your Site
No Longer an Afterthought - A Call for Greater Diversity and Inclusion in Clinical Trials
